Cristina Oliva
Directeur Technique/Scientifique/R&D chez BERGENBIO ASA
Profil
Cristina Oliva is currently the Chief Medical Officer at BerGenBio ASA since 2022.
Prior to this, she held the position of Vice President-Oncology at GSK Plc and Takeda Global Research & Development Center, Inc. She also served as VP-Oncology & Head-Oncology Excellence Centre at IQVIA Ltd.
From 2014 to 2016, she was the Chief Medical Officer at Nordic Nanovector ASA. Dr. Oliva also worked as Vice President-Oncology Global Development at Shionogi Ltd.
She holds a doctorate degree from the University of Genoa.
Postes actifs de Cristina Oliva
| Sociétés | Poste | Début |
|---|---|---|
| BERGENBIO ASA | Directeur Technique/Scientifique/R&D | 25/04/2022 |
Anciens postes connus de Cristina Oliva
| Sociétés | Poste | Fin |
|---|---|---|
| THOR MEDICAL | Directeur Technique/Scientifique/R&D | 31/01/2016 |
IQVIA Ltd.
 IQVIA Ltd. Information Technology ServicesTechnology Services IQVIA Ltd. provides professional services, information and partnering solutions. The firm serves its services to pharmaceutical, biotechnology, medical device and healthcare industries. It also provides contract research, sales, marketing, healthcare policy consulting and health information management services. The company was founded by Dennis Barry Gillings in 1995 and is headquartered in Reading, the United Kingdom. | Corporate Officer/Principal | - |
| GSK PLC | Corporate Officer/Principal | - |
| Takeda Global Research & Development Center, Inc. | Corporate Officer/Principal | - |
Shionogi Ltd.
 Shionogi Ltd. Pharmaceuticals: MajorHealth Technology Part of Shionogi & Co., Ltd., Shionogi Ltd. is a British company that manufactures and distributes pharmaceutical products. The company is based in London, UK. | Corporate Officer/Principal | - |
Formation de Cristina Oliva
| University of Genoa | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| GSK PLC | Health Technology |
| BERGENBIO ASA | Health Technology |
| Entreprise privées | 4 |
|---|---|
| Takeda Global Research & Development Center, Inc. | |
Nordic Nanovector ASA
 Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The firm offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. It operates through the following geographical segments: Norway, Switzerland, and the United Kingdom. The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, 2009 and is headquartered in Oslo, Norway. | Health Technology |
Shionogi Ltd.
Shionogi Ltd. Pharmaceuticals: MajorHealth Technology Part of Shionogi & Co., Ltd., Shionogi Ltd. is a British company that manufactures and distributes pharmaceutical products. The company is based in London, UK. | Health Technology |
IQVIA Ltd.
IQVIA Ltd. Information Technology ServicesTechnology Services IQVIA Ltd. provides professional services, information and partnering solutions. The firm serves its services to pharmaceutical, biotechnology, medical device and healthcare industries. It also provides contract research, sales, marketing, healthcare policy consulting and health information management services. The company was founded by Dennis Barry Gillings in 1995 and is headquartered in Reading, the United Kingdom. | Technology Services |
